UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 6, 2019

 

ABV Consulting, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

333-198567

 

46-3997344

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

Unit 1101-1102, 11/F, Railway Plaza

39 Chatham Road S.

Tsim Sha Tsui, Kowloon, Hong Kong

 

(Address of principal executive offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code (852) 3758-2226

 

Not applicable.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 
 
 
 

Item 8.01 Other Events

 

On October 31, 2018, the Company, through its subsidiary entered into a Memorandum of Understanding with Xinjiang Hefeng Zhitong Biotechnology Co. Ltd. (“Hefeng”). The Company and Hefeng expected to have a definitive agreement completed by the first quarter of 2019. The Company and Hefeng have mutually extended the date for the completion of the definitive agreement until August 31, 2019.

  

 

2

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ABV Consulting, Inc.

 

 

Date: May 8, 2019

By :

/s/ Jian Wei YU

 

Jian Wei YU,

President and Chief Executive Officer

 

 

3

 

ABV Consulting (CE) (USOTC:ABVN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more ABV Consulting (CE) Charts.
ABV Consulting (CE) (USOTC:ABVN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more ABV Consulting (CE) Charts.